期刊文献+

21-羟化酶缺陷症对男性生育力的影响

Effects of 21-hydroxylase deficiency on male fertility
原文传递
导出
摘要 先天性肾上腺皮质增生症(congenital adrenal hyperplasia,CAH)是由于肾上腺皮质类固醇激素合成途径中特定酶缺乏,引起皮质类固醇激素合成障碍的一组常染色体隐性遗传病。21-羟化酶缺陷(21-hydroxylase deficiency,21-OHD)是CAH最常见的类型,该疾病可导致患者的生育力受损。目前的研究多集中于女性CAH患者的生育力问题,男性21-OHD患者生育力受损最常见的原因包括睾丸肾上腺残余瘤(testicular adrenal rest tumor,TART)、低促性腺激素分泌及糖皮质激素治疗不当等。本文对男性21-OHD患者生育力受损的原因及其治疗进行了综述,旨在为改善男性21-OHD患者生育力提供指导。 Congenital adrenal hyperplasia(CAH)is a group of autosomal recessive disorders caused by deficiency of specific enzymes in the adrenocortical hormone synthesis pathway,resulting in impaired corticosteroid synthesis.21-hydroxylase deficiency is the most common type of CAH,and the disorder can lead to impaired fertility in patients.Most current studies have focused on fertility problems in female CAH patients.The most common causes of impaired fertility in men with 21-OHD include testicular adrenal rest tumors(TART),low gonadotropin secretion,and inappropriate glucocorticoid therapy.This article reviews the causes of impaired fertility and its treatment in male patients with 21-OHD,with the aim of providing guidance for improving the fertility of male patients with 21-OHD.
作者 周静 蔡芸莹 苏恒 Zhou Jing;Cai Yunying;Su Heng(Medical School,Kunming University of Science and Technology,Department of Endocrinology,The First People′s Hospital of Yunnan Province,Kunming 650500,China;Department of Endocrinology,The First People′s Hospital of Yunnan Province,Affiliated Hospital of Kunming University of Science and Technology,Kunming 650032,China)
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2023年第5期453-455,共3页 Chinese Journal of Endocrinology and Metabolism
基金 云南省卫生和计划生育委员会医学领军人才培养项目(L-201624) 云南省万人计划"名医"专项(YNWR-MY-2019-020)。
关键词 先天性肾上腺皮质增生症 21-羟化酶缺陷症 睾丸肾上腺残余瘤 男性 生育力 Congenital adrenal hyperplasia 21-Hydroxylase deficiency Testicular adrenal rest tumor Male Fertility
  • 相关文献

参考文献4

二级参考文献64

  • 1Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency : Endocrine Society clinical practice guideline [ J ]. J Clin Endocrinol Metab, 2010, 95 (9) : 41334160. DOI: 10. 1210/ jc. 2009-2631.
  • 2Miller WL. Moleeular biology of steroid hormone synthesis [ J]. Endoer Rev, 1988, 9(3) :295-318.
  • 3Gidl6f S, Wedell A, Guthenberg C, et al. Nationwide neonatal screening for congenital adrenal hyperplasia in sweden a 26-year longitudinal prospective population-based study [ J ]. JAMA Pediatr, 2014, 168 ( 6 ): 567-574. DOI: 10. 1001/ jamapediatries. 2013. 5321.
  • 4Sharma R, Seth A. Congenital adrenal hyperplasia: issues in diagnosis and treatment in children[ J]. Indian J Pediatr, 2014, 81 : (2) :178-185. DOI: 10. 1007/s120984313-1280-8.
  • 5Forest MG. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency [J]. Hum Reprod Update, 2004,10(6) :469-485.
  • 6Huynh T, McGown I, Cowley D, et al. The clinical and biochemical spectrum of congenital adrenal hyperplasia secondap/ to 21-hydroxylase deficiency [ J ]. Cfin Biochem Rev, 2009, 30 (2) :75-86.
  • 7Balsamo A, Baldazzi L, Menabb S, et al. Impact of molecular genetics on congenital adrenal hyperplasia management [ J]. Sex Dev, 2010, 4(4-5) :233-248. DOI: 10. 1159/000315959.
  • 8Forest MG. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency[J].Hum Reprod Update, 2004,10(6):469-485.
  • 9Balsamo A, Cacciari E, Baldazzi L, et al. CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romagna region [ J ]. Clin Endocrinol ( Oxf), 2000, 53(1) :117-125.
  • 10Padidela, R, Hindmarsh PC. Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia [ J ]. Int J Pediatr Endocrinol, 2010, 2010:656925. DOI: 10.1155/2010/656925.

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部